Thoughts.
Watch this space for the latest News, Top Tips, Blogs and Master Classes from Pharmora.
Our latest thinking
News
Pharmora Journal Club: PFS2 Discussion
Pharmora Journal Club explored 3 ASCO presentations looking at metastatic breast cancer and discussed what PFS2 tells us. The discussion unpacked how this emerging endpoint may help interpret benefit beyond first progression, whilst highlighting the potential issues.
Breast Cancer Awareness Month: Understanding Progress in Detection, Diagnosis, and Treatment
October is Breast Cancer Awareness Month, so Pharmora has taken the opportunity to investigate the progressing treatment landscape and look into some of the emerging treatments from some ongoing studies. Read on to learn more…
Reflections from ESMO
Hear from our Chief Medical Officer as she reflects on the highlights and hot topics from this year’s annual conference of the European Society of Medical Oncology
Top Tips
Pharmora RMP Masterclass (2): RMP Development Process -TOP TIPS
In this blog our CMO, Dr Stephanie Jones, provides detailed guidance on how to save time and effort and produce high quality risk management plans. Read on to find out more!
IDMC Tips to Help You Prepare
An Independent Data Monitoring Committee (IDMC) is a group of experts contracted to review data during a clinical trial. The members are individuals with ‘extensive clinical experience’ (Sartor et al, 2015) in that area of research, and they are independent of the Sponsor conducting the trial.
Top Tips for CSR Safety Narratives
Whether you are working with an external service provider or creating them in-house the safety narratives always cause a great deal of work right at the end of the study. This can be the busiest period when the team needs to focus on generating key messages for the completed study report (CSR) and potentially a marketing authorisation application.
Blog Posts
Pharmora Journal Club: PFS2 Discussion
Pharmora Journal Club explored 3 ASCO presentations looking at metastatic breast cancer and discussed what PFS2 tells us. The discussion unpacked how this emerging endpoint may help interpret benefit beyond first progression, whilst highlighting the potential issues.
Breast Cancer Awareness Month: Understanding Progress in Detection, Diagnosis, and Treatment
October is Breast Cancer Awareness Month, so Pharmora has taken the opportunity to investigate the progressing treatment landscape and look into some of the emerging treatments from some ongoing studies. Read on to learn more…
Reflections from ESMO
Hear from our Chief Medical Officer as she reflects on the highlights and hot topics from this year’s annual conference of the European Society of Medical Oncology
Case Studies
Unblinded Medical Review (UMR): How does it work in Pharmora?
In a follow up to the blog outlining what unblinded medical review (UMR) means and why it might be needed, this case study from one of the UMR team explains how Pharmora can support with UMR of clinical trial data.
Unblinded Medical Review (UMR): what is it and when is it needed?
In this blog we explain what UMR means and why the Sponsors of clinical trials for investigational medicinal products might need it.
Unexpected Signal Evaluations
Pharmora helped to meet a tight deadline for submitting an application for marketing approval by reviewing multiple signals to support the safety profile.
Master Class
Medical Monitoring Masterclass: Where Safety Meets Scientific Rigour
The fifth and final instalment of our Medical Monitoring Masterclass, we’re focussing on medical monitoring in generics development.
Medical Monitoring Masterclass: Medical Monitoring in Biosimilar Development
In the fourth instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’re looking at why biosimilar trials require specialist monitoring along with immunogenicity – one of the most important considerations in biosimilar development.
Medical Monitoring Masterclass: Building a Trial That Investors Will Believe In
In the second instalment of our Medical Monitoring Masterclass to celebrate Clinical Trials Day 2026, we’ve written a guide on medical monitoring for biotechs with some insights into why clinical trials are crucial.





